| Literature DB >> 24237225 |
Georgia Schäfer, Catherine H Kaschula1.
Abstract
Garlic (Allium sativum) has been used for centuries as a prophylactic and therapeutic medicinal agent. Importantly, garlic has been suggested to have both cancer-preventive potential as well as significant enhancing effects on the immune system. While these observations are supported experimentally both in vitro and in vivo, the impact of garlic in assisting the immune system in the prevention of cancer still lacks experimental confirmation. Studies addressing the immunomodulatory effects of garlic reveal conflicting data as to pro- or anti-inflammatory responses depending on the particular experimental set-ups and the garlic preparation used (i.e. garlic extract versus chemically pure garlic compounds). Here we provide an overview of the chemistry of the major garlic organosulfur compounds, summarize the current understanding and propose a link between the immunomodulating activity of garlic and the prevention of cancer. We hypothesize that garlic rather elicits anti-inflammatory and anti-oxidative responses that aid in priming the organism towards eradication of an emerging tumor.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24237225 PMCID: PMC3915757 DOI: 10.2174/18715206113136660370
Source DB: PubMed Journal: Anticancer Agents Med Chem ISSN: 1871-5206 Impact factor: 2.505
Selected studies on the immunomodulatory effects of garlic.
| Functional Component | Concentration | Experimental System | Reported Effect | Ref. |
|---|---|---|---|---|
| ajoene | 5-40 μM | Human leukemic cells | Induction of apoptosis by stimulation of peroxide production and NFκB activation | [47] |
| AGE | 500 mg daily for 6 months | Inoperable colorectal, liver or pancreatic cancer patients | Increase in NK cell number and activity | [64] |
| DAS, DADS, AMS | 5 x 20 mg daily | BALB/c mice | Enhanced number of white blood cells and antibody titre | [65] |
| Fresh garlic | 2g (once or daily for 7 days) | Healthy human volunteers | Increase in plasma NO and IFNα levels | [66] |
| Garlic extract | 0.1-10 μg/ml | Whole blood and PBMCs | Decreased production of IL12, TNFα, IL1α, IL6, IL8, IFNγ, IL2; increase of IL10 | [67] |
| Garlic extract | 10-1000 μg/ml | Normal placental and preeclamptic explants | Inhibition of IL6 and TNFα production; IL10 increase (10μg/ml garlic extract) or IL10 decrease (1000μg/ml garlic extract) | [68] |
| Garlic powder extract | 10-100 mg/l | LPS-induced human whole blood | Reduction of NFκB activity and production of IL1β and TNFα | [69] |
| DAS | 1-10 μM | LPS-stimulated RAW 264.7 macrophages | Reduction of iNOS expression and NO production; Reduction of COX2 expression and PGE2 release (only DAS) | [70] |
| AGE | 0.1-5 g/l | Ox-LDL induced injury in endothelial cells | Prevention of membrane damage, loss of cell viability and lipid peroxidation by prevention of intracellular GSH depletion and NFκB activation | [71] |
| Alliin | 0.05-3 μg/ml | LPS-induced PMBCs | Increase in IL1β and TNFα; Decrease in IL6 production | [73] |
| DADS, DATS | 50-400 μM | LPS-stimulated RAW 264.7 macrophages | Reduction of iNOS expression, NO and peroxide production; Inhibition of NFκB activation | [74] |
| ajoene | IC50 2.5-5 μM | LPS-stimulated RAW 264.7 macrophages | Reduction of iNOS expression and NO accumulation | [75] |
| DAS | 1-10 μM | LPS-stimulated RAW 264.7 macrophages | Inhibition of TNFα, IL1β, IL6, IL10 production; Inhibition of NO and prostaglandin PGE2 release | [76] |
| ajoene | IC50 2.4-3.4 μM | LPS-stimulated RAW 264.7 macrophages | Inhibition of COX2 enzyme activity and PGE2 release | [77] |